Participants with advanced ( unresectable, recurrent or metastatic) solid research hub

DT-9081 trial in participants with advanced solid tumours.

This study is for adults with advanced cancers that have spread or can't be removed by surgery. It's the first time the new medicine, DT-9081, is being tested in people. Doctors want to see if it's safe and how it works against these cancers.